Genetic ablation of CCR5 (i.e., CCR5 knockout mice) results in the increase of infarction size and exacerbation of motor functional deficits after experimental stroke [22], demonstrating neuroprotective effects of CCR5 in ischemic brain injury. The gene discussed is CCR5; the disease is stroke disorder.